Patents by Inventor Francis O'Donnell, JR.

Francis O'Donnell, JR. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9026372
    Abstract: The present invention provides methods of treating subjects with an oxazaphosphorines, methods of identifying subjects that are suitable for oxazaphosphorine treatment, and systems for ensuring the safety and efficacy of a treatment that includes oxazaphosphorine administration.
    Type: Grant
    Filed: May 27, 2010
    Date of Patent: May 5, 2015
    Assignee: Accentia Biopharmaceuticals, Inc.
    Inventors: Francis O'Donnell, Jr., Carlos Santos
  • Publication number: 20110117050
    Abstract: The present invention provides methods of treating subjects with an oxazaphosphorines, methods of identifying subjects that are suitable for oxazaphosphorine treatment, and systems for ensuring the safety and efficacy of a treatment that includes oxazaphosphorine administration.
    Type: Application
    Filed: May 21, 2010
    Publication date: May 19, 2011
    Applicant: Accentia Biopharmaceuticals, Inc.
    Inventors: FRANCIS O'DONNELL, JR., Carlos Santos
  • Publication number: 20110097426
    Abstract: The present invention provides methods of treating subjects with an oxazaphosphorines, methods of identifying subjects that are suitable for oxazaphosphorine treatment, and systems for ensuring the safety and efficacy of a treatment that includes oxazaphosphorine administration.
    Type: Application
    Filed: May 21, 2010
    Publication date: April 28, 2011
    Applicant: Accentia Biopharmaceuticals, Inc.
    Inventors: FRANCIS O'DONNELL, JR., Carlos Santos
  • Publication number: 20110082115
    Abstract: The present invention provides methods of treating subjects with an oxazaphosphorines, methods of identifying subjects that are suitable for oxazaphosphorine treatment, and systems for ensuring the safety and efficacy of a treatment that includes oxazaphosphorine administration.
    Type: Application
    Filed: May 27, 2010
    Publication date: April 7, 2011
    Applicant: Accentia Biopharmaceuticals, Inc.
    Inventors: Francis O'Donnell, JR., Carlos Santos